MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$753,000
-25.4%
22,746
-4.2%
0.01%
-20.0%
Q4 2021$1,010,000
-4.8%
23,733
-0.9%
0.01%
-9.1%
Q3 2021$1,061,000
-28.3%
23,954
-8.1%
0.01%
-26.7%
Q2 2021$1,480,000
-27.4%
26,055
-4.3%
0.02%
-28.6%
Q1 2021$2,039,000
-17.8%
27,235
-5.1%
0.02%
-25.0%
Q4 2020$2,482,000
+38.4%
28,691
-2.3%
0.03%
+16.7%
Q3 2020$1,794,000
+26.8%
29,356
-13.8%
0.02%
+20.0%
Q2 2020$1,415,000
+108.7%
34,036
+44.1%
0.02%
+81.8%
Q1 2020$678,000
-60.2%
23,616
+0.2%
0.01%
-50.0%
Q4 2019$1,702,000
-8.9%
23,577
+77.0%
0.02%
-15.4%
Q3 2019$1,869,000
-36.7%
13,323
-17.4%
0.03%
-38.1%
Q2 2019$2,954,000
+15.2%
16,133
+0.1%
0.04%
+13.5%
Q1 2019$2,564,000
+69.0%
16,123
+1.8%
0.04%
+48.0%
Q4 2018$1,517,000
-32.2%
15,8360.0%0.02%
-21.9%
Q3 2018$2,237,000
-42.9%
15,836
-36.8%
0.03%
-44.8%
Q2 2018$3,921,000
-30.9%
25,050
-28.9%
0.06%
-34.1%
Q1 2018$5,672,000
-2.6%
35,215
-0.4%
0.09%
-1.1%
Q4 2017$5,825,000
+150.3%
35,365
-5.3%
0.09%
+134.2%
Q3 2017$2,327,000
+1.7%
37,346
+29.9%
0.04%
-5.0%
Q2 2017$2,289,000
+2952.0%
28,746
+2637.7%
0.04%
+3900.0%
Q1 2017$75,0001,0500.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 475,600$15,362,0005.31%
Integral Health Asset Management, LLC 412,257$13,316,0002.74%
Palo Alto Investors LP 851,409$27,501,0002.40%
Boxer Capital, LLC 1,094,000$35,336,0002.24%
DAFNA Capital Management LLC 180,306$5,824,0001.59%
Ikarian Capital, LLC 250,000$8,075,0001.47%
Bellevue Group AG 2,973,178$96,034,0001.36%
SECTOR GAMMA AS 118,476$3,827,0000.86%
Artal Group S.A. 450,000$14,535,0000.78%
Diametric Capital, LP 19,393$626,0000.46%
View complete list of SAGE THERAPEUTICS INC shareholders